Immunotherapy News and Research

Latest Immunotherapy News and Research

Study reveals low detection of SARS-CoV-2 on environmental surfaces across oncology settings

Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.

7 Dec 2020

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Roswell Park Comprehensive Cancer Center's Francisco J. Hernandez-Ilizaliturri, MD, along with a team of researchers from other institutions, has been investigating a novel therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

7 Dec 2020

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

A study led by The University of Texas MD Anderson Cancer Center showed that first-line treatment with a regimen of chemotherapy combined with the monoclonal antibody blinatumomab resulted in increased survival and achieved a high rate of measurable residual disease (MRD) negativity for patients who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative B-cell ALL (Ph-negative B-ALL).

7 Dec 2020

Study finds CAR T cell therapy as effective as first-line treatment for high-risk large B-cell lymphoma

A study led by researchers at The University of Texas MD Anderson Cancer Center found that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, is a safe and effective first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), a group with an urgent need for new and effective treatments.

7 Dec 2020

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators from Hackensack Meridian Health John Theurer Cancer Center (JTCC), a member of the Georgetown Lombardi Comprehensive Cancer Center consortium, are to present updates on treatment advances in multiple myeloma (MM), mantle cell lymphoma (MCL), and other types of B-cell lymphoma (BCL) as well as leukemia at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, to be held virtually from December 5-8, 2020.

7 Dec 2020

Study proposes new plan to help reduce financial hardships for cancer patients

Until you or a loved one are facing treatment for a cancer diagnosis, you may not realize the cost associated with treatment and doctor visits.

6 Dec 2020

ESMO honors 2020 recipients for advancing the field of oncology

The global coronavirus pandemic has disrupted cancer research, prevention and treatment to an extent never seen before. To sustain the development of medical knowledge and therapeutic progress for patients worldwide, particular attention must now be paid to the future of the discipline - and to the individuals who continue to work tirelessly to make it evolve.

4 Dec 2020

Study offers hope to parents and kids who face real danger from peanut exposure

It's a peanut-filled world--or at least it can feel that way for kids with peanut allergies. But a new study by researchers at the University of British Columbia and BC Children's Hospital gives hope to parents and kids who face real danger from exposure to peanuts.

3 Dec 2020

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.

3 Dec 2020

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.

2 Dec 2020

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

Treatments that harness the immune system to fight cancer have greatly improved outcomes for some people with cancer. Scientists are learning more about why some people respond much better than others to these drugs.

2 Dec 2020

CNRS develops new patented technique that reveals energy status of cells

A procedure that may help personalise anticancer therapies has just been developed by the CNRS, INSERM, and Aix-Marseille University scientists at the Centre d'Immunologie de Marseille-Luminy, in association with colleagues from the University of California San Francisco and the Marseille Public University Hospital System (AP-HM), with support from Canceropôle Provence-Alpes-Côte d'Azur.

2 Dec 2020

Researchers study SerpinB9 protein that could pave way to new immunotherapy approach

Immunotherapies have transformed the landscape of cancer treatment by allowing physicians to alter or augment patients' immune response to better attack malignant tumors.

2 Dec 2020

Gut microbiota directly shapes the makeup of human immune system, shows study

MSK researchers have uncovered an important finding about the relationship between the microbiota and the immune system, showing for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.

1 Dec 2020

Immunotherapy News and Research

Latest Immunotherapy News and Research

Study reveals low detection of SARS-CoV-2 on environmental surfaces across oncology settings

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

Study finds CAR T cell therapy as effective as first-line treatment for high-risk large B-cell lymphoma

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Study proposes new plan to help reduce financial hardships for cancer patients

ESMO honors 2020 recipients for advancing the field of oncology

Study offers hope to parents and kids who face real danger from peanut exposure

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

Surprising discovery reveals new target for aggressive lung adenocarcinoma

Study: Tumors with high TMB tend to respond better to immune checkpoint inhibitors

CNRS develops new patented technique that reveals energy status of cells

Researchers study SerpinB9 protein that could pave way to new immunotherapy approach

Gut microbiota directly shapes the makeup of human immune system, shows study

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

Combination therapy found to be effective against treatment-resistant hepatocellular carcinoma

Penn study opens the door to let CAR T cells reach the tumor microenvironment

‘Molecular clock’ blood test could help identify actively growing tumors in metastatic breast cancer

Study unravels the immunogenicity of ferroptotic cancer cells

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in